Financhill
Back

Zoetis 10K Form

Buy
63

ZTS
Zoetis

Last Price:
171.94
Seasonality Move:
8.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive ZTS News And Ratings

See the #1 stock for the next 7 days that we like better than ZTS

ZTS Financial Statistics

Sales & Book Value

Annual Sales: $8.54B
Cash Flow: $455M
Price / Cash Flow: 45.83
Annual Sales: $11.07
Price / Book: 15.7

Profitability

EPS (TTM): 5.19000
Net Income (TTM): $2.39B
Gross Margin: $5.98B
Return on Equity: 49.34%
Return on Assets: 17.02%

Zoetis Earnings Forecast

Key Zoetis Financial Ratios

  • The Gross Profit Margin over the past 15 years for ZTS is 70.03%.
  • The Selling, General & Administrative Expenses for ZTS have been equal to 25.18% of Gross Profit Margin.
  • The Research & Development expenses have been 7.19% of Revenue.
  • The Interest Expense is 10.20% of Operating Income.
  • The Net Earning history of ZTS is 27.43% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 13 years.

Zoetis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ZTS
CUSIP: 98978V
Website: zoetis.com

Debt

Debt-to-Equity Ratio: 1.3
Current Ratio: 3.33
Quick Ratio: 1.71

Price-to-Earnings

Trailing P/E Ratio: 34.33
Forward P/E Ratio: 27.31

ZTS Technical Analysis vs Fundamental Analysis

Buy
63
Zoetis (ZTS) is a Buy

Is Zoetis a Buy or a Sell?

  • Zoetis stock is rated a Buy
    The current Zoetis [ZTS] share price is $172.79. The Score for ZTS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.